eleven patients with 16 infections due to enterobacteriaceae or pseudomonas that were in most cases refractory to treatment with cephalosporins , kanamycin , gentamicin , tobramycin , carbenicillin , or ampicillin ( administered singly or in combinations ) received 1 g of amikacin daily by the intramuscular route ( 10 patients ) or 0.4 g daily ( one patient with renal insufficiency ) .
C0022487
kanamycin
C0002499
amikacin